ArticleJournal for immunotherapy of cancer2020

Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker.

Bingxi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.